| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/16/2008 | WO2007133373A3 TNF-α VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-α |
| 10/16/2008 | WO2007126832A3 Pharmaceutical compositions for prevention of overdose or abuse |
| 10/16/2008 | WO2007123777A3 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses |
| 10/16/2008 | WO2007123761A3 Methylation of estrogen receptor alpha and uses thereof |
| 10/16/2008 | WO2007117682A3 Mature dendritic cell compositions and methods for culturing same |
| 10/16/2008 | WO2007115230A3 A strategy for homo- or hetero-dimerization of various proteins in solutions and in cells |
| 10/16/2008 | WO2007100905A3 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation |
| 10/16/2008 | WO2007100874A3 Compositions containing peptides with non-natural amino acids and methods of use |
| 10/16/2008 | WO2007087576A3 Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases |
| 10/16/2008 | WO2007087053A3 Bmp-7 variant compositions, methods and uses |
| 10/16/2008 | WO2007012944A9 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 10/16/2008 | WO2007011610A3 Protein formulation for promoting hard tissue formation |
| 10/16/2008 | WO2006138355A3 Effect of bri proteins on abeta production |
| 10/16/2008 | WO2006078717A3 Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis |
| 10/16/2008 | WO2006069329A3 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 10/16/2008 | US20080255643 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 10/16/2008 | US20080255339 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities |
| 10/16/2008 | US20080255248 Coupling a stabilizing group-oligopeptide conjugate with the free therapeutic agent, binding with a polymeric resin forming a therapeutic agent-polymeric resin complex; high specificity of action, a reduced toxicity, an improved stability in the serum and blood |
| 10/16/2008 | US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease |
| 10/16/2008 | US20080255073 Compounds for sustained release of orally delivered drugs |
| 10/16/2008 | US20080255056 Salts of isophosphoramide mustard and analogs thereof |
| 10/16/2008 | US20080255055 Use of Derivatives of Dipeptides for the Manufacture of of a Medicament for the Treamtent of Microbial Infections |
| 10/16/2008 | US20080255054 Lyophilizates of active, excipients, carriers, bulking agents; medicaments for benign or malignant neoplastic diseases, hormone therapy, treatment of fertility disorders, contraception, HIV infections, neurological or neurodegenerative disorders; high bioavailability |
| 10/16/2008 | US20080255053 By administering a luteinizing hormone releasing hormone (LHRH) antagonist such as cetrorelix, teverelix, ganirelix, antide, or abarelix for 4-12 weeks, then ceasing treatment; endometriosis |
| 10/16/2008 | US20080255052 Immunologic regulation by theta defensins |
| 10/16/2008 | US20080255051 Use to treat dyslipidemic disorders, stroke and myocardial infarction; isolated polypeptide of given sequence; labeled peptide for use in visualization of plaque |
| 10/16/2008 | US20080255050 Administering 2-aminopurine or a pharmaceutically salt thereof; optionally also administering an additional hypolipidemic agent; 2-AP and nonphosphorylatable eIF-2 alpha mutant inhibit eIF-2 alpha phosphorylation, inhibit foam cell formation and atherosclerosis development |
| 10/16/2008 | US20080255049 Use of low intensity pulsed ultrasound while administering osteogenic proteins or genes enhances bone repair in mammals; combination avoids thermal activation of tissue repair mechanisms and allows osteogenic proteins to act at site of bone fracture or lowered bone density to accelerate bone formation |
| 10/16/2008 | US20080255048 Comprising a poly (amino acid) as the active ingredient, e.g. a peptide or protein, showing a rapid disintegration and/or dissolution; delivery of drugs in a pharmaceutically effective amount, particularly poly (amino acids) such as peptides, peptidomimetics and proteins, e.g. hormones |
| 10/16/2008 | US20080255047 Method of Treating Acute Renal Failure with Thrombomobulin Variant |
| 10/16/2008 | US20080255046 Y2 Selective Receptor Agonists for Therapeutic Interventions |
| 10/16/2008 | US20080255045 Modified FGF-21 Polypeptides and Their Uses |
| 10/16/2008 | US20080255044 EPH gene expression inhibition to facilitate tissue repair arising from disease or injuries of the nervous system; treatment of spinal cord injury as well as other central nervous system diseases such as Alzheimer's disease, Parkinson's disease and multiple sclerosis |
| 10/16/2008 | US20080255043 SP-D induces and increases apoptosis specifically in activated eosinophils derived from hypereosinophilic patients for the resolution of eosinophilia and eosinophil mediated pathogenic effects in eosinophil related diseases and disorders other than airway-hyperresponsiveness |
| 10/16/2008 | US20080255042 CaSR Antagonist |
| 10/16/2008 | US20080255041 Compositions and methods for treating tears, fissures, or openings in the annulus fibrosis of an intervertebral disc, for example, such as those resulting from degenerative disc disease or discectomy; enhanced healing |
| 10/16/2008 | US20080255040 Polypeptide with amino acid sequences including exogenous glycosylated sequences; libraries |
| 10/16/2008 | US20080255039 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69 |
| 10/16/2008 | US20080255038 3-[(R)-2-(N,N-dimethylamino)ethylthio-Sar]-4-(gamma-hydroxymethylleucine)cyclosporin, for example, and pharmaceutical compositions prepared from the same, in combination with one or more NS5B polymerase inhibitors; use in treatment of hepatitis C virus; avoids need to use interferon or ribavirin |
| 10/16/2008 | US20080255037 Endoparasiticidal Compositions |
| 10/16/2008 | US20080255036 Substituted thiophenes |
| 10/16/2008 | US20080255035 Sparc and methods of use thereof |
| 10/16/2008 | US20080255034 Apparatus comprises an ablator that is configured to generate a microporation in area of skin of patient, and comprising a drug which effects biological regulation of at least one of oocyte containing follicle, stimulation of follicle growth, induction of ovulation, promotion of gestational status |
| 10/16/2008 | US20080255033 Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds |
| 10/16/2008 | US20080255032 Methods and compositions for preventing and treating aging or photodamaged skin |
| 10/16/2008 | US20080255031 Method for enhancing insulin secretion |
| 10/16/2008 | US20080255030 Compositions and methods for the modulation of jnk proteins |
| 10/16/2008 | US20080255029 Neuroendocrine Tumor Treatment |
| 10/16/2008 | US20080255028 Collagen Receptor I-Domain Binding Modulators |
| 10/16/2008 | US20080255027 Purification of biomolecules such as proteins, polypeptides, antibodies and the like by use of a stimuli responsive polymer, such as a solubilized or soluble polymer to capture the desired biomolecules from a solution/suspension by precipitation mechanism and then to further purify them |
| 10/16/2008 | US20080255026 Glycopegylated Factor Ix |
| 10/16/2008 | US20080255025 Protease inhibition |
| 10/16/2008 | US20080254542 Reference Solution |
| 10/16/2008 | US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE |
| 10/16/2008 | US20080254506 Claudin polypeptides |
| 10/16/2008 | US20080254152 Inhibiting glucocorticoid-induced chronic stress in a dermal cell or a cell involved in skin inflammatory responses |
| 10/16/2008 | US20080254145 Anti-tumor drug, medicament, composition, and use thereof |
| 10/16/2008 | US20080254142 Compositions and methods for nutrition supplementation |
| 10/16/2008 | US20080254119 nutritional supplement tablet comprises an oily liquid Vitamin E finely dispersed in an oil insoluble material; providing lubrication; free of magnesium stearate, free of undesirable problem; increase bonding, compressibility and tablet hardness |
| 10/16/2008 | US20080254109 Delivering therapeutic nucleic acid into adjacent normal heart tissue; inducing angiogenesis and collateral blood vessel formation |
| 10/16/2008 | US20080254108 Formulations and Methods for Modulating Satiety |
| 10/16/2008 | US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 10/16/2008 | US20080254095 Delivery device and method for forming the same |
| 10/16/2008 | US20080254093 Compositions and minimally invasive methods for treating dysfunction of cardiac muscle |
| 10/16/2008 | US20080254091 Multi-Layered Antiadhesion Barrier |
| 10/16/2008 | US20080254087 Methods For Administering Hypoglycemic Agents |
| 10/16/2008 | US20080254086 Gonadotropin-releasing hormone active agent in a sustained mean steady state plasma concentration of 1.5 ng/mL for 48 hours; implant dosage form is a fiber, needle, rod, sheet, film, particle or microparticle; poly(lactide)s, poly(glycolide)s, poly(lactide-co-glycolide)s, poly(lactic acid)s substrate |
| 10/16/2008 | US20080254079 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology |
| 10/16/2008 | US20080254078 Simple, binary system of hydrophilic nanoparticles using cationic chitosan and anionic polysaccharides having carboxymethyl groups and/or sulfate groups; adjustable zeta potential of aqueous colloidal suspensions; binding biological groups covalently; drug delivery; foods; cosmetics; biocompatability |
| 10/16/2008 | US20080254050 Immunotherapeutic comprising very small particles from neisserial outer memebrane protein and/or vascular endothelial growth factor for use in targeting a nd treating cell proliferative, inflammatory autoimmune and vision defects |
| 10/16/2008 | US20080254045 Therapeutic mixture comprising a non-specific cluster of differentiation-1 (CD1d) complex which comprises beta 2-microglobulin and binds ceramide-like glycolipid antigens for use in treatment of autoimmune disorders |
| 10/16/2008 | US20080254041 Raising immunoglobulins with high specificity for environmental and/or commercial allergens |
| 10/16/2008 | US20080254040 Antagonists of receptors of enothelial growth factor, platelet-derived growth factor, fibroblast growth factor, epidermal growth factors, HER2, IGF1R, HGFR or c-Kit, which is further an antagonist of a src tyrosine kinase family member, and chemotherapeutic agent; co-treatment with radiation therapy |
| 10/16/2008 | US20080254039 Prevention of Thrombus Formation and/or Stabilization |
| 10/16/2008 | US20080254036 Contains [2-({4-[(dimethylamino)iminomethyl]phenyl}carbonylamino)-5-methoxyphenyl]-N-(5-chloro(2-pyridyl))carboxamide (betrixaban) and antiplatelet agent for treatment of thrombosis; kits |
| 10/16/2008 | US20080254035 Expression vector comprising lipocalin gene sequences for use in prevention and treatment of cell proliferative, inflammatory, autoimmune and cardiovascular disorders |
| 10/16/2008 | US20080254031 Nucleotide sequences coding tumor antigens for use as diagnostic tool in detection and staging of cell proliferative disorders |
| 10/16/2008 | US20080254030 Using B cell survival factor (BAFF) agonist as therapeutic in treatment of asthma |
| 10/16/2008 | US20080254029 Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis |
| 10/16/2008 | US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders |
| 10/16/2008 | US20080254023 Using erythropoietin-producing hepatocelluar kinase receptor specific interfering RNA for treatment and prevention of brain, nervous system and spinal cord disorders |
| 10/16/2008 | US20080254019 Therapeutic Agents and Therapeutic Methods For Treating Injured Tissue |
| 10/16/2008 | US20080254018 Solid support comprising stably conjugated neovascularizing protein for use in identifying modulators of cell proliferation |
| 10/16/2008 | US20080254017 Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids |
| 10/16/2008 | US20080254015 For application to wounds; bacteriostats |
| 10/16/2008 | US20080254009 Using probiotic culture comprising metronidazole, bacitracin or vancomycin as therapeutic in treatment of diarrhea and inflammatory bowel diseases |
| 10/16/2008 | US20080253998 Treatment of cancer using tlr3 agonists |
| 10/16/2008 | US20080253997 Compositions and methods for protecting cells from toxic exposures |
| 10/16/2008 | US20080253996 Using stromal cell-derived factor-1 (SDF-1) to treat traumatic nerve injury, pain, multiple sclerosis a nd stroke |
| 10/16/2008 | US20080253995 For treatment of Flaviviridae infection, including hepatitis C virus, West Nile Virus, yellow fever virus, and rhinovirus infection |
| 10/16/2008 | US20080253994 Methods and Compositions for Contributing to the Treatment of Cancers |
| 10/16/2008 | US20080253993 Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope |
| 10/16/2008 | US20080253992 Using hydrophobic interaction chromatography to recover therapeutic fusion protein for use in treatment of injuries associated with ischemia, trauma, inflammation and contact with toxic substances |
| 10/16/2008 | US20080253991 Using glutamic acid decarboxylase (GAD) autoantigen, cd3 specific antibodies and lymphocyte specific antibodies to treat and prevent new onset type I diabetes in mammals |
| 10/16/2008 | US20080253990 Using thymidine defective grampositive microorganism to deliver interleukin therapeutic for use in treatment of inflammatory bowel disease |
| 10/16/2008 | US20080253989 Neuron Regeneration |
| 10/16/2008 | US20080253988 Pyrrolo [1,2-D] [1,2-4] Triazine as Inhibitors of C-Jun N Terminal Kinases (Jnk) and P-38 Kinases |
| 10/16/2008 | US20080253971 Particles for inhalation having sustained release properties |
| 10/16/2008 | US20080253960 Cell surface receptor ligand is covalently bonded to apoprotein; photodynamic therapy; antiglaucoma agents |
| 10/16/2008 | CA2720097A1 Raav vector compositions having tyrosine-modified capsid proteins and methods for use |